Washington, D.C. (June 13, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding health care reform:
“We remain committed to working with the Administration and Congress to help enact comprehensive health care reform this year. We share a common goal: every single American should have access to affordable, high-quality healthcare coverage and services.
”PhRMA has long-supported public health initiatives to turn back the epidemic of chronic illness that is driving up healthcare costs in our country. Today, treatment of chronic conditions accounts for 75 percent of all healthcare spending. Reducing the need for healthcare services because fewer Americans have costly conditions like cancer, diabetes and heart disease will save lives and save money too.
“A lot of work remains to be done, but we will continue to share ideas and seek solutions with the relevant committees in Congress, as well as the White House, in hopes that our shared vision for a reformed healthcare system becomes a reality this year.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.
PhRMA Internet Address: www.phrma.org
For information on how innovative medicines save lives, visit: www.innovation.org
For information on the Partnership for Prescription Assistance, visit: www.pparx.org
For more information on public health emergencies, visit: www.rxresponse.org